InsiderTrades

Form 4 for KWY KINGSWAY Corp

Accepted 2022-12-16 00:00:00 ET · period of report 2022-12-15 · accession 0001127602-22-027655 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-12-16 2022-12-16 KWY Hansen Kent A CFO, EVP P - Purchase $7.30 +205 105.7K +0.2% +$1,496
2022-12-16 2022-12-15 KWY Hansen Kent A CFO, EVP A - Grant $7.17 +25.1K 105.5K +31% +$180.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Commoon Stock 2022-12-16 P A 205 $7.30 105,749 D — — (F4) The shares of Common Stock were acquired pursuant to the Kingsway America Inc. Employee Share Purchase Plan, as amended and restated effective May 29, 2014 (the "ESPP"). Pursuant to the ESPP, eligible employees may contribute an amount up to 5% of adjusted salary for each regular payroll period and, to the extent such employee has been employed by Kingsway America Inc. and its subsidiaries for 12 months, the company will make a matching contribution equal to 100% of such employee's contribution. The employee contributions and company contributions are used to purchase, as soon as administratively practicable after the date of such contributions, shares of Kingsway Financial Services Inc. The shares are acquired by the administrator of the ESPP on the open market through the services of a duly registered stockbroker. (F3) Includes 21,836 shares of restricted stock granted on December 3, 2021.
2 Common Commoon Stock 2022-12-15 A A 25,111 $7.17 105,544 D — — (F1) Restricted stock award granted pursuant to the Kingsway Financial Services Inc. 2020 Equity Incentive Plan that vests ratably over three years commencing on December 1, 2023 (F2) The number of shares represented by this award was determined by dividing the dollar value of the award granted to the Reporting Person by $7.168 (the volume-weighted average of the closing sale prices of the Issuer's common stock on the NYSE?for each of the thirty (30) trading days immediately prior to the grant date). (F3) Includes 21,836 shares of restricted stock granted on December 3, 2021.